Literature DB >> 35801988

Effects of state opioid prescribing cap laws on opioid prescribing after surgery.

Ian Schmid1, Elizabeth A Stuart1,2,3, Alexander D McCourt2, Kayla N Tormohlen2, Elizabeth M Stone2, Corey S Davis4, Mark C Bicket5,6, Emma E McGinty1,2.   

Abstract

OBJECTIVE: To evaluate the effects of state opioid prescribing cap laws on opioid prescribing after surgery. DATA SOURCES: OptumLabs Data Warehouse administrative claims data covering all 50 states from July 2012 through June 2019. STUDY
DESIGN: We included individuals from 20 states that had implemented prescribing cap laws without exemptions for postsurgical pain by June 2019 and individuals from 16 control states plus the District of Columbia. We used a difference-in-differences approach accounting for differential timing in law implementation across states to estimate the effects of state prescribing cap laws on postsurgical prescribing of opioids. Outcome measures included filling an opioid prescription within 30 days after surgery; filling opioid prescriptions of specific doses or durations; and the number, days' supply, daily dose, and pill quantity of opioid prescriptions. To assess the validity of the parallel counterfactual trends assumption, we examined differences in outcome trends between law-implementing and control states in the years preceding law implementation using an equivalence testing framework. DATA COLLECTION/EXTRACTION
METHODS: We included the first surgery in the study period for opioid-naïve individuals undergoing one of eight common surgical procedures. PRINCIPAL
FINDINGS: State prescribing cap laws were associated with 0.109 lower days' supply of postsurgical opioids on the log scale (95% Confidence Interval [CI]: -0.139, -0.080) but were not associated with the number (Average treatment effect on the treated [ATT]: -0.011; 95% CI: -0.043, 0.021) or daily dose of postsurgical opioid prescriptions (ATT: -0.013; 95% CI: -0.030, 0.005). The negative association observed between prescribing cap laws and the probability of filling a postsurgical opioid prescription (ATT: -0.041; 95% CI: -0.054, -0.028) was likely spurious, given differences between law-implementing and control states in the pre-law period.
CONCLUSIONS: Prescribing cap laws appear to have minimal effects on postsurgical opioid prescribing.
© 2022 Health Research and Educational Trust.

Entities:  

Keywords:  causal inference; difference-in-differences; law; opioid; postsurgical pain

Mesh:

Substances:

Year:  2022        PMID: 35801988      PMCID: PMC9441291          DOI: 10.1111/1475-6773.14023

Source DB:  PubMed          Journal:  Health Serv Res        ISSN: 0017-9124            Impact factor:   3.734


  35 in total

1.  New Persistent Opioid Use After Minor and Major Surgical Procedures in US Adults.

Authors:  Chad M Brummett; Jennifer F Waljee; Jenna Goesling; Stephanie Moser; Paul Lin; Michael J Englesbe; Amy S B Bohnert; Sachin Kheterpal; Brahmajee K Nallamothu
Journal:  JAMA Surg       Date:  2017-06-21       Impact factor: 14.766

2.  The Effect of State Legislation on Opioid Prescriptions Following Arthroscopic Rotator Cuff Repair.

Authors:  Christopher M McDowell; Alexandria K Bradian; Quincy T Cheesman; Sundeep S Saini; Kristen J Nicholson; Fotios P Tjoumakaris; Luke S Austin
Journal:  Orthopedics       Date:  2020-10-01       Impact factor: 1.390

3.  Mandatory Prescription Limits and Opioid Utilization Following Orthopaedic Surgery.

Authors:  Daniel B C Reid; Kalpit N Shah; Benjamin H Shapiro; Jack H Ruddell; Edward Akelman; Alan H Daniels
Journal:  J Bone Joint Surg Am       Date:  2019-05-15       Impact factor: 5.284

4.  Effects of state opioid prescribing cap laws on opioid prescribing after surgery.

Authors:  Ian Schmid; Elizabeth A Stuart; Alexander D McCourt; Kayla N Tormohlen; Elizabeth M Stone; Corey S Davis; Mark C Bicket; Emma E McGinty
Journal:  Health Serv Res       Date:  2022-07-29       Impact factor: 3.734

5.  Limitations on Postoperative Opioid Prescriptions and Effects on Health Care Resource Use Following Elective Anterior Cervical Discectomy and Fusion.

Authors:  Brice A Kessler; Brainard Burrus; Greeshma Somashekar; Samuel P Wurzelmann; Deb Bhowmick
Journal:  World Neurosurg       Date:  2020-10-27       Impact factor: 2.104

6.  Defining Optimal Length of Opioid Pain Medication Prescription After Common Surgical Procedures.

Authors:  Rebecca E Scully; Andrew J Schoenfeld; Wei Jiang; Stuart Lipsitz; Muhammad Ali Chaudhary; Peter A Learn; Tracey Koehlmoos; Adil H Haider; Louis L Nguyen
Journal:  JAMA Surg       Date:  2018-01-01       Impact factor: 14.766

7.  Vital Signs: Changes in Opioid Prescribing in the United States, 2006-2015.

Authors:  Gery P Guy; Kun Zhang; Michele K Bohm; Jan Losby; Brian Lewis; Randall Young; Louise B Murphy; Deborah Dowell
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-07-07       Impact factor: 17.586

8.  Trends and Patterns of Geographic Variation in Opioid Prescribing Practices by State, United States, 2006-2017.

Authors:  Lyna Z Schieber; Gery P Guy; Puja Seth; Randall Young; Christine L Mattson; Christina A Mikosz; Richard A Schieber
Journal:  JAMA Netw Open       Date:  2019-03-01

Review 9.  Prescription Opioid Analgesics Commonly Unused After Surgery: A Systematic Review.

Authors:  Mark C Bicket; Jane J Long; Peter J Pronovost; G Caleb Alexander; Christopher L Wu
Journal:  JAMA Surg       Date:  2017-11-01       Impact factor: 14.766

10.  Changes in Prescribing by Provider Type Following a State Prescription Opioid Restriction Law.

Authors:  Ivelisse L Valdes; Marie-Christin Possinger; Juan M Hincapie-Castillo; Amie J Goodin; Marvin A Dewar; Jill M Sumfest; Scott M Vouri
Journal:  J Gen Intern Med       Date:  2021-07-08       Impact factor: 6.473

View more
  1 in total

1.  Effects of state opioid prescribing cap laws on opioid prescribing after surgery.

Authors:  Ian Schmid; Elizabeth A Stuart; Alexander D McCourt; Kayla N Tormohlen; Elizabeth M Stone; Corey S Davis; Mark C Bicket; Emma E McGinty
Journal:  Health Serv Res       Date:  2022-07-29       Impact factor: 3.734

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.